I believe MYX new board and management deserve a chance to prove themselves before we paint them with the same brush of previous management.
I believe the purchase of the Therapeutics products is sound and money well spent if they deliver on what has been said.
So, my analysis of new products' contribution for FY2024 below is based on :
1. It will be marketed by current Nextellis sales team
2. Additional US$20M marketing costs
3. Royalty payments to Therapeutics and Population Council
4. Not taking into account the stated strategy of marketing direct to consumers, which could boost revenue significantly (as per dermatology).
5. the last 9 months of trading by Therapeutics (US$68.3M) -(Significantly hampered by loss of staff and their ongoing woes)
6. Gross Profit %(81.8%) as per Therapeutics
As a speculative aside, I believe the Capital Return will be cancelled and used for purchasing the rights for distribution of Donesta in the US. Mithra has already granted those rights to Gideon Richter for distribution in Europe, Brazil, Australia, NZ
but interestingly not the US . Gideon has agreed to pay 55M Euros for the rights.
New Prod $A 1 Revenue $130.15 2 Gross Profit $106.48 3 %Profit 81.82% 4 Op. Expenses $45.38 5 Total Costs $69.04 6 Contribution $61.11
- Forums
- ASX - By Stock
- MYX
- Some Analysis
Some Analysis
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
SBW
Shekel Brainweigh reports a 50% revenue increase in its Retail Innovation suite and delivers the first batch of 20 Smart Bays to Hitachi as part of a larger order
BM8
Learn of the ASX-listed company that is well-placed to respond to the future global energy demand
Add MYX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.70 |
Change
-0.120(2.49%) |
Mkt cap ! $399.8M |
Open | High | Low | Value | Volume |
$4.71 | $4.80 | $4.65 | $775.9K | 164.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 85 | $4.69 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.72 | 1079 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 85 | 4.690 |
3 | 2488 | 4.680 |
2 | 688 | 4.670 |
2 | 688 | 4.660 |
4 | 6688 | 4.650 |
Price($) | Vol. | No. |
---|---|---|
4.720 | 1079 | 1 |
4.740 | 874 | 2 |
4.750 | 874 | 2 |
4.760 | 745 | 1 |
4.780 | 129 | 1 |
Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online